Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 39

Results For "2022"

1412 News Found

Orchid Pharma Q4 FY23 consolidated PAT up at Rs. 59.13 Cr
News | May 11, 2023

Orchid Pharma Q4 FY23 consolidated PAT up at Rs. 59.13 Cr

The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023


Lupin posts Q4FY23 consolidated PAT up at Rs. 235.96 Cr
News | May 10, 2023

Lupin posts Q4FY23 consolidated PAT up at Rs. 235.96 Cr

The company has reported total income of Rs. 4467.35 crores during the quarter ended March 31, 2023


IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market
Drug Approval | May 09, 2023

IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market

The certification issued by the EDQM verifies the compliance of pharmaceutical substances


Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr
News | May 07, 2023

Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023


Alembic Pharmaceuticals posts Q4FY2023 consolidated PAT at Rs. 152.60 Cr
News | May 07, 2023

Alembic Pharmaceuticals posts Q4FY2023 consolidated PAT at Rs. 152.60 Cr

The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023


Ajanta pharma posts Q4FY23 consolidated PAT at Rs. 122.25 Cr
News | May 06, 2023

Ajanta pharma posts Q4FY23 consolidated PAT at Rs. 122.25 Cr

The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023


Mandaviya reviews organ donation policy
Policy | May 04, 2023

Mandaviya reviews organ donation policy

Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022


CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
News | May 03, 2023

CPHI & PMEC China 2023 to see surge from pent up international ingredients demand

China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey


USFDA Advisory Committee votes  n Lynparza plus Abiraterone and Prednisone  for prostate cancer
Drug Approval | May 03, 2023

USFDA Advisory Committee votes n Lynparza plus Abiraterone and Prednisone for prostate cancer

The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients


IMCD Colombia acquires pharma API distributor Allianz
Supply Chain | May 03, 2023

IMCD Colombia acquires pharma API distributor Allianz

Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market